-
x
x
bid
ask
08:03 PM
Bearish
32
Bullish
138
sentiment
day range
52 week range
Prev Close
Open
Low
High
Volume0.00
Avg. Volume0.00
Market Cap0.00
Inst. Own
Beta
Short Ratio
Div & Yield /
EPS
P/E
1yr Target
50day MA
200day MA
CNQ.TO
Canadian Natural Resources Limited
106.52
04:00 PM
+
0.84
0.79%
G.TO
Augusta Gold Corp.
0.96
03:59 PM
-
0.07
6.80%
AAA.AX
BetaShares Australian High Interest Cash ETF
50.25
02:10 AM
+
0.01
0.02%
ACC.NS
ACC Limited
2533.05
05:59 AM
-
46.55
1.80%
600690.SS
Haier Smart Home Co., Ltd.
28.35
03:00 AM
-
0.08
0.28%
0700.HK
Tencent Holdings Limited
348.40
04:08 AM
+
9.00
2.65%
1101.TW
Taiwan Cement Corp.
31.80
01:30 AM
-
0.20
0.62%
20MICRONS.NS
20 Microns Limited
162.85
05:59 AM
+
5.90
3.76%
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
News
...
Profile
...
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
Earning
...
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2023-05-11 | 2023-03 | 0 | N/A | N/A | N/A |
2023-03-31 | 2022-12 | -1.93 | N/A | N/A | N/A |
2022-11-10 | 2022-09 | -2.82 | N/A | N/A | N/A |
2022-08-11 | 2022-06 | -1.25 | N/A | N/A | N/A |
2022-05-12 | 2022-03 | -1.25 | N/A | N/A | N/A |
2022-03-10 | 2021-12 | -2.5 | N/A | N/A | N/A |
Upgrade / Downgrade
...
Date | Firm | Action | From | To |
---|---|---|---|---|
2020-11-06 | SVB Leerink | Upgrade | Outperform | |
2020-11-25 | H.C. Wainwright | Upgrade | Buy | |
2020-11-25 | Canaccord Genuity | Upgrade | Buy | |
2020-11-25 | H.C. Wainwright | Upgrade | Buy | |
2020-11-25 | Leerink Swann | Upgrade | Outperform | Outperform |
2020-11-25 | Canaccord Genuity | Upgrade | Buy | Buy |
Insider Holder
...
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-17 | Becker (Lisa Ann McFadde) | Senior Officer of Issuer | 2.45K | Exercise of rights |
2022-06-21 | Clark, Christopher John | Senior Officer of Issuer | 49.10K | Exercise of rights |
2022-06-21 | Colen (Fredericus A) | Senior Officer of Issuer | 224.15K | Exercise of rights |
2022-08-17 | Gallagher (Sarah Marie Hodgson) | Senior Officer of Issuer | 1.46K | Exercise of rights |
2022-11-17 | Geyer (Paul) | 10% Security Holder of Issuer | 18.34K | Acquisition or disposition in the public market |
2022-08-18 | Janzen (Doug) | Director of Issuer | 38.78K | Acquisition or disposition in the public market |
Institution Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-12-30 | Natixis | 49.78K | 1.49M | 1.84% |
2022-12-30 | U.S. Capital Wealth Advisors, LLC | 18.78K | 563.96K | 0.69% |
2022-12-30 | Magnetar Financial LLC | 15.80K | 474.59K | 0.58% |
2022-12-30 | Choreo, LLC | 12.44K | 373.57K | 0.46% |
2022-12-30 | Morgan Stanley | 3.64K | 109.16K | 0.13% |
2022-12-30 | Bank of America Corporation | 2.70K | 81.11K | 0.10% |
Fund Ownership
...
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-11-29 | Fidelity NASDAQ Composite Index Fund | 854.00 | 25.65K | 0.03% |
Split
...
Split | Date |
---|---|
1 : 25 | 2022-04-29 |
1 : 10 | 2019-07-02 |
1 : 100 | 2018-09-21 |
This topic has been deleted. Only users with topic management privileges can see it.
-
Mergers and Acquisitions in 2023 Off To A Strong Start
marketbeat.com • -
Shockwave Medical To Buy Neovasc: Details (NVCN)
pulse2.com • -
Neovasc Inc. (NVCN) Q3 2022 Earnings Call Transcript
seekingalpha.com • -
Neovasc to Participate in H.C. Wainwright Global Investment Conference
globenewswire.com • -
Neovasc to Report First Quarter Financial Results on May 12, 2022
newsfilecorp.com • -
Neovasc to Participate in H.C. Wainwright BIOCONNECT Virtual Conference
globenewswire.com • -
Neovasc to Report Third Quarter 2021 Financial Results on November 9, 2021
globenewswire.com • -
Neovasc REDUCER-I Study Published in EuroIntervention Journal
globenewswire.com • -
Why Are Neovasc Shares Moving Higher On Thursday?
benzinga.com • -
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
globenewswire.com • -
Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDA
newsfilecorp.com • -
Neovasc Announces Second Quarter 2021 Financial Results
newsfilecorp.com • -
Neovasc to Report Second Quarter 2021 Financial Results on August 10, 2021
globenewswire.com • -
Neovasc Announces New Appointments in Regulatory and Clinical Leadership
globenewswire.com • -
Neovasc Provides Corporate Update
newsfilecorp.com • -
Neovasc Provides Corporate Update
globenewswire.com • -
Neovasc Reducer System Receives First National Reimbursement in Europe
globenewswire.com • -
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
newsfilecorp.com • -
Neovasc Inc. Reports Results of Annual General Meeting of Shareholders
globenewswire.com • -
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
globenewswire.com • -
Neovasc Provides Update on German Litigation
newsfilecorp.com • -
Neovasc to Sponsor Symposium on Reducer at EuroPCR
newsfilecorp.com • -
Neovasc to Sponsor Symposium on Reducer at EuroPCR
globenewswire.com • -
Neovasc Announces First Patient Enrollment in COSIMA Trial
globenewswire.com • -
Neovasc Announces First Quarter 2021 Financial Results
newsfilecorp.com • -
Neovasc Provides Reducer Reimbursement Progress Update
globenewswire.com • -
Neovasc to Report First Quarter 2021 Financial Results on May 6, 2021
newsfilecorp.com • -
Neovasc Comments on EuroIntervention Article
newsfilecorp.com • -
Neovasc Provides Tiara TA Update
newsfilecorp.com • -
Neovasc Provides Tiara TA Update
globenewswire.com • -
Neovasc Announces Fourth Quarter and Fiscal Year 2020 Financial Results
newsfilecorp.com • -
Neovasc to Participate in 2021 H.C. Wainwright Global Life Sciences Conference
globenewswire.com • -
Neovasc Comments on Clinical Cardiology Journal Publication
globenewswire.com • -
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
newsfilecorp.com • -
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
globenewswire.com • -
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
newsfilecorp.com • -
Neovasc Comments on Journal of the American Heart Association Publication
newsfilecorp.com • -
American Medical Association Issues New CPT Code for Neovasc Reducer Procedure
globenewswire.com • -
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer(TM)
newsfilecorp.com • -
Neovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer™
globenewswire.com • -
Neovasc Announces Publication of Peer-Reviewed Article in EuroIntervention
newsfilecorp.com • -
Neovasc Announces First Neovasc Reducer(TM) Implants in France
newsfilecorp.com • -
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
newsfilecorp.com • -
Neovasc Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
globenewswire.com • -
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
globenewswire.com •